These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10971795)

  • 1. Hyperhomocysteinaemia and activated protein C resistance in Behçet's disease.
    Altinbaş A; Aytemur K; Tokgözoğlu L; Oztürk M; Koşar A; Haznedaroğlu IC; Kirazli S; Dündar SV
    J Intern Med; 2000 Sep; 248(3):267-8. PubMed ID: 10971795
    [No Abstract]   [Full Text] [Related]  

  • 2. Does hyperhomocysteinemia increase the risk of thrombosis in Behçet's disease?
    Houman H; Feki M; Ghorbel IB; Gadhoum H; Hsairi M; Omar S; Lamloum M; Kaabachi N; Mebazaa A; Miled M
    Adv Exp Med Biol; 2003; 528():413-7. PubMed ID: 12918735
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal pulmonary artery thrombosis in a patient with Behçet's disease, activated protein C resistance and hyperhomocystinemia.
    Misgav M; Goldberg Y; Zeltser D; Eldor A; Berliner AS
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):421-3. PubMed ID: 10937802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease.
    Lesprit P; Wechsler B; Piette JC; Du-Boutin LT; Godeau P; Alhenc-Gelas M; Aiach M
    Ann Rheum Dis; 1995 Oct; 54(10):860. PubMed ID: 7492231
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein C and protein S activities in Behçet's disease as risk factors of thrombosis.
    Lenk N; Ozet G; Alli N; Coban O; Erbaşi S
    Int J Dermatol; 1998 Feb; 37(2):124-5. PubMed ID: 9542668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behçet's disease as a prethrombotic state.
    Haznedaroğlu S; Karaaslan Y; Haznedaroğlu IC; Dündar SV
    Int J Clin Lab Res; 1998; 28(3):200. PubMed ID: 9801934
    [No Abstract]   [Full Text] [Related]  

  • 8. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
    Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
    Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin, iron, vitamin B12, and folic acid deficiencies and hyperhomocysteinemia in Behcet's disease patients with atrophic glossitis.
    Wu YH; Yu-Fong Chang J; Wang YP; Wu YC; Chen HM; Sun A
    J Formos Med Assoc; 2018 Jul; 117(7):559-565. PubMed ID: 29572125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activated protein C resistance in Behçet disease].
    Guermazi S; M'Rad S; Lamloum M; Houman MH; Hamza M; Ben Dridi M; Miled M; Dellagi K
    Pathol Biol (Paris); 1998 Dec; 46(10):791-5. PubMed ID: 9922996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombosis of the superior mesenteric artery and Behçet's syndrome].
    Mercié P; Constans J; Tissot B; Sebban A; Gorin G; Rullier E; Morlat P; Beylot J; Conri C
    Rev Med Interne; 1996; 17(6):470-3. PubMed ID: 8758534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracardiac thrombosis: unusual complication of Behcet's disease].
    Fekih M; Fennira S; Ghodbane L; Zaouali RM
    Tunis Med; 2004 Aug; 82(8):785-90. PubMed ID: 15532777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein S deficiency and antibodies to protein S in patients with Behçet's disease.
    Guermazi S; Hamza M; Dellagi K
    Thromb Res; 1997 May; 86(3):197-204. PubMed ID: 9175241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
    Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
    Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis with Behçet's disease should be evaluated different conditions.
    Balta I; Balta S; Demir M; Ozturk C; Demirkol S
    Pan Afr Med J; 2015; 20():117. PubMed ID: 26090065
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
    Nalçaci M; Pekçelen Y
    J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasma levels of activated thrombin activatable fibrinolysis inhibitor and thrombomodulin in Behçet disease and their association with thrombosis.
    Donmez A; Aksu K; Aydin H; Keser G; Cagirgan S; Doganavsargil E; Tombuloglu M
    Thromb Res; 2010 Sep; 126(3):207-10. PubMed ID: 20542541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
    Mader R; Ziv M; Adawi M; Mader R; Lavi I
    J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.